Clinical Trial Update: Evaluate Safety and Efficacy of Autologous Bone Marrow-derived Endothelial Progenitor Cells in Advanced Liver Cirrhosis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating safety and efficacy of autologous bone marrow-derived endothelial progenitor cells in advanced liver cirrhosis. The study st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis

Drugs mentioned

• Autologous bone marrow-derived endothelial progenitor cells (Endothelial progenitor cells)

Snippet

Sponsor: Clinica Universidad de Navarra, Universidad de Navarra | Conditions: Liver Cirrhosis | Phase 1, Phase 2 | Status: COMPLETED